Table 2.
Abstinence Rates by Treatment Group
| Continuous Abstinence1 % Abstinent (n) | 7-Day Point Prevalence2 % Abstinent (n) | Prolonged Abstinence3 % Abstinent (n) | |
|---|---|---|---|
| End of Treatment | |||
| CBASP Group (n= 128) | ----- | 45.3 (58) | ----- |
| HW Group (n= 129) | ----- | 39.2 (51) | ----- |
| OR 1.2., 95% CI [0.7–2.0] | |||
| 3 Months after End of Treatment | |||
| CBASP Group | 23.4 (30) | 36.7 (47) | 31.3 (40) |
| HW Group | 21.0 (27) | 31.0 (40) | 27.1 (35) |
| OR 1.2, 95% CI [0.6–2.1] | OR 1.3, 95% CI [0.8–2.2] | OR 1.2, 95% CI [0.7–2.1] | |
| 6 Months after End of Treatment | |||
| CBASP Group | 11.1 (14) | 18.0 (23) | 14.1 (18) |
| HW Group | 8.5 (11) | 16.3 (21) | 14.7 (19) |
| OR 1.3, 95% CI [0.6–3.0] | OR 1.1, 95% CI [0.6–2.2] | OR 1.0, 95% [CI 0.5–2.0] | |
| 3 Months Postpartum | |||
| CBASP Group | 11.7 (15) | 18.8 (24) | 16.4 (21) |
| HW Group | 10.9 (14) | 17.8 (23) | 18.6 (24) |
| OR 1.1, 95% CI [0.6–2.0] | OR 1.1, 95% CI [0.5–2.4] | OR 0.9, 95% [CI 0.5–1.7] | |
| 6 Months Postpartum | |||
| CBASP Group | 3.1 (4) | 7.0 (9) | 7.8 (10) |
| HW Group | 1.2 (3) | 9.3 (12) | 6.2 (8) |
| OR 1.7, 95% CI [0.4–7.3] | OR 0.8, 95% CI [0.3–1.8] | OR 1.3, 95% CI [0.5–3.4] |
Note. No significant treatment group differences in abstinence were noted. CBASP = Cognitive Behavioral Analysis System of Psychotherapy; HW = Health and Wellness.
1
Continuous abstinence is defined as no smoking on any day.
2
7-day point prevalence is defined as no smoking in the last seven days of the given time period.
3
Prolonged abstinence; relapse is defined by smoking for 7 or more consecutive days or by smoking at least 1 cigarette over two consecutive weeks.